Cosmo Pharmaceuticals N.V. (ETR:C43)
Germany
· Delayed Price · Currency is EUR 50.00
0.00 (0.00%)
At close: Apr 17, 2025, 5:30 PM CET
Cosmo Pharmaceuticals Revenue
In the year 2024, Cosmo Pharmaceuticals had annual revenue of 266.79M EUR with 187.55% growth. Cosmo Pharmaceuticals had revenue of 130.55M in the half year ending December 31, 2024, with 115.51% growth.
Revenue
266.79M
Revenue Growth
+187.55%
P/S Ratio
2.98
Revenue / Employee
828.53K
Employees
322
Market Cap
793.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 266.79M | 174.01M | 187.55% |
| Dec 31, 2023 | 92.78M | -9.31M | -9.12% |
| Dec 31, 2022 | 102.09M | 37.02M | 56.88% |
| Dec 31, 2021 | 65.07M | 4.13M | 6.77% |
| Dec 31, 2020 | 60.95M | -1.55M | -2.47% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Deutsche Telekom AG | 118.43B |
| Siemens Aktiengesellschaft | 76.54B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 9.75B |
| Merck KGaA | 21.16B |
| Siemens Energy AG | 35.76B |